Prakiraan pendapatan perusahaan AC Immune Inc (ACIU)
The target product realization level in the indicator's chronology on the GURU.Markets chart correlates with the colossal costs and risks associated with developing Alzheimer's drugs. The high authority of AC Immune (ACIU) in targeted therapy is confirmed by partnerships with industry leaders. Meanwhile, 0.03 captures the current value of the indicator as the company attracts elite neurobiologists through RSUs and stable R&D funding.
Rincian metrik lan analitis perusahaan AC Immune S.A. (ACIU)
- rega saiki lan proyeksi nilai saham:
- rincian kapitalisasi pasar:
- data ekuitas miturut neraca:
- rincian struktur utang lan likuiditas bisnis:
Total Utang marang Modal AC Immune|ACIU - Rasio utang jangka dawa marang ekuitas|Utang jangka cendhak marang modal AC Immune Corp|ACIU - Gunggung kewajiban utang perusahaan|Utang marang nilai buku AC Immune S.A.|ACIU - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan AC Immune|Rasio cepet acimmune.com
- statistik bathi lan rasio pasar:
ACIU - Penghasilan resik perusahaan|Bathi mangsa ngarep AC Immune|ACIU - Pangali P/E|Rega marang bathi mangsa ngarep AC Immune SA|ACIU - Koefisien bali modal nimbang wutah|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan AC Immune S.A.|ACIU - Bathi sadurunge bunga, pajak, lan amortisasi|Bathi resik saben saham (EPS TTM) AC Immune|ACIU - Bathi resik saben saham (EPS TTM)|Wutah bathi EPS kuartalan acimmune.com|ACIU - Wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi saben saham kanggo taun ngarep AC Immune
- data dodolan lan asil:
Analisis dhasar perusahaan:AC Immune ACIU
A comparative asset analysis requires an assessment of potential revenue by discounting expected cash flows from future commercial drug launches. This model measures the probability of monetizing R&D assets, which for AC Immune (ACIU) is supported by its authority in Alzheimer's disease therapy and partnerships with pharma behemoths, determining the company's final projected sales level.
Analisis perusahaan pesaing
Volume dodolan mangsa ngarep perusahaan BIIB (Biogen Inc.)|Prakiraan volume dodolan neurocrine.com (NBIX)|Prakiraan pendapatan perusahaan Regencell Bioscience Holdings Limited RGC|AXSM: Prakiraan pendapatan perusahaan|ACADIA Pharmaceuticals Inc - Prakiraan volume dodolan|Volume dodolan sing dikarepake perusahaan Xenon Corp|VKTX: Prakiraan volume dodolan|supernus.com (SUPN) - Prakiraan volume dodolan|CPRX (Catalyst Pharmaceuticals, Inc.) - Prakiraan volume dodolan|Volume dodolan mangsa ngarep perusahaan Denali (DNLI)|Prakiraan volume dodolan HRMY|Dodolan mangsa ngarep perusahaan Biohaven Corp|Amylyx Pharmaceuticals - Volume dodolan mangsa ngarep perusahaan|Prakiraan volume dodolan trevitherapeutics.com TRVI|PRAX - Prakiraan pendapatan perusahaan|AVXL (Anavex) - Prakiraan pendapatan perusahaan|CBLL: Prakiraan volume dodolan|Volume dodolan sing dikarepake perusahaan Prothena Corp (PRTA)|Volume dodolan mangsa ngarep perusahaan ALEC|Prakiraan volume dodolan annexonbio.com|Prakiraan pendapatan perusahaan Omeros Corporation (OMER)|NGNE (Neurogene Inc) - Pendapatan mangsa ngarep perusahaan|Prakiraan pendapatan perusahaan Voyager Pharma VYGR|Neumora Corp (NMRA) - Volume dodolan sing dikarepake perusahaan|Scilex Holding Company - Prakiraan volume dodolan|TVGN - Prakiraan volume dodolan|ACOG: Prakiraan volume dodolan|Volume dodolan mangsa ngarep perusahaan cogrx.com|Volume dodolan mangsa ngarep perusahaan IKT|SAVA: Pendapatan mangsa ngarep perusahaan|Prakiraan volume dodolan ASRT|Dodolan mangsa ngarep perusahaan coyatherapeutics.com|Prakiraan pendapatan perusahaan Vistagen VTGN|OVID - Volume dodolan mangsa ngarep perusahaan|ABOS - Prakiraan pendapatan perusahaan|CervoMed Corporation (CRVO) - Volume dodolan mangsa ngarep perusahaan|ATHE (alteritytherapeutics.com) - Volume dodolan mangsa ngarep perusahaan|Clene (CLNN) - Prakiraan volume dodolan|Prakiraan pendapatan perusahaan PepGen Inc|Prakiraan pendapatan perusahaan JUNS (jupiterneurosciences.com)|Prakiraan volume dodolan RLMD|ANVS - Volume dodolan sing dikarepake perusahaan|Prakiraan volume dodolan GRCE (Grace Therapeutics)|Prakiraan volume dodolan fireflyneuro.com AIFF|ANEW Medical, Inc. - Prakiraan volume dodolan|NeuroSense Therapeutics (NRSN) - Volume dodolan mangsa ngarep perusahaan|RVPH: Prakiraan volume dodolan|MTVA - Dodolan mangsa ngarep perusahaan|Volume dodolan mangsa ngarep perusahaan NRXS|Prakiraan volume dodolan Helius Medical Technologies Inc.|Prakiraan pendapatan perusahaan Passage Bio, Inc. (PASG)|bionomics.com.au - Prakiraan pendapatan perusahaan|Prakiraan volume dodolan NERV (Minerva Neurosciences Corp)|Athira Pharma Corp (ATHA) - Volume dodolan sing dikarepake perusahaan|ADXN: Volume dodolan mangsa ngarep perusahaan|ALZN - Prakiraan volume dodolan|cyclerion.com (CYCN) - Prakiraan pendapatan perusahaan|Protagenic Therapeutics, Inc. - Pendapatan mangsa ngarep perusahaan|Prakiraan pendapatan perusahaan Pasithea Therapeutics Corp|Volume dodolan sing dikarepake perusahaan Cortigent Medical CRGT|Prakiraan volume dodolan ATXI|Prakiraan volume dodolan brainstorm-cell.com (BCLI)|Prakiraan volume dodolan CARA (Cara Therapeutics)|CHRO - Volume dodolan mangsa ngarep perusahaan|ELYM: Volume dodolan mangsa ngarep perusahaan|Pendapatan mangsa ngarep perusahaan ITCI (Intra-Cellular Therapies)|LBPH: Prakiraan volume dodolan|MRNS - Dodolan mangsa ngarep perusahaan|Prakiraan pendapatan perusahaan NKGen Biotech|Volume dodolan mangsa ngarep perusahaan NeuroBo Pharmaceuticals Inc (NRBO)|Prakiraan pendapatan perusahaan Sage Therapeutics, Inc (SAGE)|Volume dodolan mangsa ngarep perusahaan Synaptogenix, Inc SNPX|Trevena, Inc. - Volume dodolan mangsa ngarep perusahaan|Prakiraan volume dodolan Vigil Neuroscience Inc. VIGL|WENA - Prakiraan pendapatan perusahaan|CERE (Cerevel Therapeutics Inc) - Prakiraan pendapatan perusahaan
